Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1977 1
1979 1
1982 2
1983 3
1984 4
1985 4
1986 3
1987 6
1988 3
1989 4
1990 1
1991 7
1992 4
1993 3
1994 4
1995 10
1996 14
1997 5
1998 6
1999 8
2000 10
2001 8
2002 10
2003 9
2004 10
2005 8
2006 14
2007 16
2008 11
2009 11
2010 26
2011 16
2012 12
2013 19
2014 17
2015 9
2016 2
2017 5
2018 5
2019 9
2020 7
2021 6
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

316 results

Results by year

Filters applied: . Clear all
Page 1
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study.
von der Maase H, Hansen SW, Roberts JT, Dogliotti L, Oliver T, Moore MJ, Bodrogi I, Albers P, Knuth A, Lippert CM, Kerbrat P, Sanchez Rovira P, Wersall P, Cleall SP, Roychowdhury DF, Tomlin I, Visseren-Grul CM, Conte PF. von der Maase H, et al. Among authors: knuth a. J Clin Oncol. 2000 Sep;18(17):3068-77. doi: 10.1200/JCO.2000.18.17.3068. J Clin Oncol. 2000. PMID: 11001674 Corrected and republished. Clinical Trial.
Virus-like particles for vaccination against cancer.
Mohsen MO, Speiser DE, Knuth A, Bachmann MF. Mohsen MO, et al. Among authors: knuth a. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Jan;12(1):e1579. doi: 10.1002/wnan.1579. Epub 2019 Aug 27. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020. PMID: 31456339 Free PMC article. Review.
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.
Al-Batran SE, Hartmann JT, Probst S, Schmalenberg H, Hollerbach S, Hofheinz R, Rethwisch V, Seipelt G, Homann N, Wilhelm G, Schuch G, Stoehlmacher J, Derigs HG, Hegewisch-Becker S, Grossmann J, Pauligk C, Atmaca A, Bokemeyer C, Knuth A, Jäger E; Arbeitsgemeinschaft Internistische Onkologie. Al-Batran SE, et al. Among authors: knuth a. J Clin Oncol. 2008 Mar 20;26(9):1435-42. doi: 10.1200/JCO.2007.13.9378. J Clin Oncol. 2008. PMID: 18349393 Clinical Trial.
Classification of current anticancer immunotherapies.
Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G. Galluzzi L, et al. Among authors: knuth a. Oncotarget. 2014 Dec 30;5(24):12472-508. doi: 10.18632/oncotarget.2998. Oncotarget. 2014. PMID: 25537519 Free PMC article. Review.
[Cancer immunotherapy--current status].
Kundig TM, Renner Ch, Knuth A. Kundig TM, et al. Among authors: knuth a. Ther Umsch. 2006 Apr;63(4):262-6. doi: 10.1024/0040-5930.63.4.262. Ther Umsch. 2006. PMID: 16689457 Review. German.
[Molecular targeted therapy].
Stenner-Liewen F, Zippelius A, Pestalozzi BC, Knuth A. Stenner-Liewen F, et al. Among authors: knuth a. Chirurg. 2006 Dec;77(12):1118-25. doi: 10.1007/s00104-006-1262-8. Chirurg. 2006. PMID: 17109101 Free article. Review. German.
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study.
von der Maase H, Hansen SW, Roberts JT, Dogliotti L, Oliver T, Moore MJ, Bodrogi I, Albers P, Knuth A, Lippert CM, Kerbrat P, Sanchez Rovira P, Wersall P, Cleall SP, Roychowdhury DF, Tomlin I, Visseren-Grul CM, Conte PF. von der Maase H, et al. Among authors: knuth a. J Clin Oncol. 2023 Aug 10;41(23):3881-3890. doi: 10.1200/JCO.22.02763. J Clin Oncol. 2023. PMID: 37549482
Clinical cancer vaccine trials.
Jäger E, Jäger D, Knuth A. Jäger E, et al. Among authors: knuth a. Curr Opin Immunol. 2002 Apr;14(2):178-82. doi: 10.1016/s0952-7915(02)00318-7. Curr Opin Immunol. 2002. PMID: 11869889 Review.
Developments in cancer immunotherapy.
van den Broek M, von Boehmer L, Knuth A. van den Broek M, et al. Among authors: knuth a. Dig Dis. 2010;28(1):51-6. doi: 10.1159/000282064. Epub 2010 May 7. Dig Dis. 2010. PMID: 20460890 Free article. Review.
Imagine a world without cancer.
Brücher BL, Lyman G, van Hillegersberg R, Pollock RE, Lordick F, Yang HK, Ushijima T, Yeoh KG, Skricka T, Polkowski W, Wallner G, Verwaal V, Garofalo A, D'Ugo D, Roviello F, Steinau HU, Wallace TJ, Daumer M, Maihle N, Reid TJ 3rd, Ducreux M, Kitagawa Y, Knuth A, Zilberstein B, Steele SR, Jamall IS. Brücher BL, et al. Among authors: knuth a. BMC Cancer. 2014 Mar 14;14:186. doi: 10.1186/1471-2407-14-186. BMC Cancer. 2014. PMID: 24629025 Free PMC article.
316 results